European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission
The Lancet Oncology, November 2022
Cancer World publication: Mark Lawler comments on the conclusions of a UK consensus group (September 2022)
United efforts to accelerate drug development
European Pharmaceutical Review, December 2021
Access to Personalised Oncology in Europe : a report by LSE consulting, commissioned by EFPIA and contributed by the CDDF (November 2020)
ESMO provides first recommendations on use of next-generation sequencing in metastatic cancer
Cancerworld, September 2020
Verweij, J., Hendriks, H.R., Zwierzina, H. (2019) – on behalf of the CDDF. Innovation in oncology clinical trial design. Cancer Treatment Reviews, 74, 15-20.
https://doi.org/10.1016/j.ctrv.2019.01.001
Biomarkers and patients’ access to personalised oncology drugs in Europe
Open Access Government, January 2019
The use of real-world data in cancer drug development
European Journal of Cancer (EJC), Volume 101, pp. 69-76, September 2018
Access the article in PDF format.
The Current and Future Challenges of Personalised Cancer Therapy
Open Access Government, April 2018
5th Immunotherapy of Cancer Conference (ITOC5), 19-21 March 2018, Berlin, Germany – Abstract Book
European Journal of Cancer (EJC), Volume 92, Supplement 1, S1-S26, March 2018
Implementing liquid biopsies into clinical decision making for cancer immunotherapy
Oncotarget, doi: 10.18632/oncotarget.17397, April 2017
4th Immunotherapy of Cancer Conference (ITOC4), 20-22 March 2017, Prague, Czech Republic – Abstract Book
Journal for Immunotherapy of Cancer 2017 5 (Suppl 1):12, 20 March 2017
Accelerating progress in immunotherapy
Cancerworld, n°71 – Cutting Edge section, pp. 29, March, April, 2016
Regulators Embrace Immunotherapy
J. Smyth – The ASCO Post, 25 March 2016
3rd Immunotherapy of Cancer Conference (ITOC3), 21-23 March 2016, Munich, Germany – Abstract Book
European Journal of Cancer (EJC), Volume 55, Supplement 1, March 2016
Access to innovative oncology medicines in Europe
L. Bergmann, H. Enzmann, S. Thirstrup, J. K. Schweim, I. Widera, and H. Zwierzina
Ann. Onc. 2016 27: 353-356, November 2015
2nd Immunotherapy of Cancer Conference (ITOC2), 25-27 March 2015, Munich, Germany – Abstract Book
European Journal of Cancer (EJC), Volume 51, Issue S1, pp. S1-S14, March 2015
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer
European Journal of Cancer (EJC), Volume 51, Issue 2, pp. 218-224, January 2015